As of Mar 24
| -0.0174 / -2.43%|
The 4 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a +685.71% increase from the last price of 0.70.
The current consensus among 5 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.